Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 382,653 | 442,646 | 380,834 | 418,175 | 368,872 |
| Cost of Goods | 188,221 | 193,574 | 180,596 | 192,258 | 162,038 |
| Gross Profit | 194,432 | 249,072 | 200,238 | 225,917 | 206,834 |
| Operating Expenses | 210,150 | 214,020 | 208,984 | 229,204 | 202,908 |
| Operating Income | -15,497 | 35,626 | -8,150 | -3,029 | 3,964 |
| Interest Expense | 18,815 | 18,984 | 19,373 | 18,651 | 13,624 |
| Other Income | 4,276 | 5,898 | 7,161 | 6,495 | 4,430 |
| Pre-tax Income | -30,036 | 22,540 | -20,362 | -15,185 | -5,230 |
| Income Tax | -4,743 | 3,106 | -9,667 | -2,783 | -1,949 |
| Net Income Continuous | -25,293 | 19,434 | -10,695 | -12,402 | -3,281 |
| Net Income | $-25,293 | $19,434 | $-10,695 | $-12,402 | $-3,281 |
| EPS Basic Total Ops | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| EPS Basic Continuous Ops | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| EPS Diluted Total Ops | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| EPS Diluted Continuous Ops | -0.33 | 0.25 | -0.14 | -0.16 | -0.04 |
| EPS Diluted Before Non-Recurring Items | 0.41 | 0.97 | 0.41 | 0.63 | N/A |
| EBITDA(a) | $23,076 | $74,615 | $29,146 | $35,208 | $35,928 |